AIM ImmunoTech Announces IRB Approval to Enroll COVID-19 ‘Long Haulers’ in the AMP-511 ME/CFS Clinical Trial of Ampligen

NEXT STORY
City of Hope launches AccessHope™, a wholly owned subsidiary dedicated to providing a first-of-its-kind, innovative cancer support model for employers to improve care, experience, outcomes and value
PREV STORY
Dental Implants Market to Exhibit 5.1% CAGR and Reach USD 5725 Million by 2026; Straumann to Dominate with its Diverse Product Portfolio, says Fortune Business Insights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Karyopharm Appoints Anand Varadan as Chief Commercial Officer and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

-- Formerly of Chiasma, Amgen and Procter and Gamble, Brings Over 25 Years of ...

author_avatar
NASDAQ Market News

Plasma Therapy Market to Show Tremendous Growth by 2020 due to COVID-19 | Leading Players – DePuy Synthes Companies, Grifols, Kedrion Biopharma, Octapharma, Stryker, Baxter International Inc., Terumo BCT, Biotest AG, Arthrex

author_avatar
NASDAQ Market News

Consistente bevindingen inzake veiligheid en langdurige werkzaamheid na behandeling van reumapatiënten met filgotinib na 84 weken in DARWIN 3 studie

Galapagos presenteert data uit DARWIN 3, andere filgotinibstudies en GLPG1972 van Galapagos op de ...

author_avatar
NASDAQ Market News